Back to search

Article

Roles of PPARα and PPARγ As Regulator of Free Fatty Acids in Nonalcoholic Steatohepatitis

2023-04-14

Abstract excerpt

In recent years, nonalcoholic fatty liver disease/steatohepatitis (NAFLD/NASH) has become a leading worldwide disease, and its therapies are facing many complexities. Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear receptor (NR) superfamily and have three subtypes: PPARα (NR1C1), PPARβ/δ (NR1C2), and PPARγ (NR1C3). They have been identified...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cfc03328-38ba-5578-b571-4f170c6a75a9
DOI
10.20944/preprints202304.0356.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Roles of PPARα and PPARγ As Regulator of Free Fatty Acids in Nonalcoholic SteatohepatitisDOI 10.20944/preprints202304.0356.v1
The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver DiseaseSemantic proximity
Peroxisome proliferator activated receptors and obesity.Semantic proximity
Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver DiseaseSemantic proximity
Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.Semantic proximity
Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review.Semantic proximity
Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARsSemantic proximity
Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver diseaseSemantic proximity
PPARα as a therapeutic target in inflammation-associated diseasesSemantic proximity
The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH modelSemantic proximity
SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic StrategiesSemantic proximity
Peroxisome Proliferator-Activated Receptor-γ: Master Regulator of Adipogenesis and ObesitySemantic proximity
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.Semantic proximity
Select a neighboring publication to make it the new centre.